Wall Street Analysts Initiate Coverage on Otis, Stryker, and Johnson Controls

Key Facts

1Evercore initiated coverage on Otis Worldwide (OTIS) with an 'outperform' rating and a $100 price target.

2Evercore initiated coverage on Johnson Controls (JCI) with an 'in-line' rating and a $155 price target.

3Leerink Partners initiated coverage on Stryker (SYK) with an 'outperform' rating and a $410 price target following strong earnings.

Major Wall Street financial institutions have initiated research coverage on three significant industrial and medical companies listed on the NYSE. Evercore began coverage on Otis Worldwide with an 'outperform' rating and a $100 price target, while assigning an 'in-line' rating to Johnson Controls with a $155 target. In the medical sector, Leerink Partners initiated coverage on Stryker with an 'outperform' rating and a $410 price target, following the company's robust earnings performance. These initiations reflect a generally positive outlook on the industrial and healthcare sectors, providing updated valuation benchmarks for investors. The new coverage is expected to drive market sentiment and potentially increase buying pressure for the involved equities.